Detalhe da pesquisa
1.
Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations.
Gynecol Oncol
; 160(3): 786-792, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33375991
2.
Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: A large prospective single institution experience.
Gynecol Oncol
; 157(2): 514-520, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32199636
3.
Inherited mutations in fallopian tube, ovarian and primary peritoneal carcinoma: Changes in diagnoses and mutational frequency over 20 years.
Gynecol Oncol
; 159(1): 214-220, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32709535
4.
An Alternate Diagnostic Algorithm for the Diagnosis of Intraepithelial Fallopian Tube Lesions.
Int J Gynecol Pathol
; 39(3): 261-269, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31033800
5.
Tumor infiltrating lymphocytes and homologous recombination deficiency are independently associated with improved survival in ovarian carcinoma.
Gynecol Oncol
; 153(2): 217-222, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30803719
6.
Clinical characteristics and outcomes of patients with BRCA1 or RAD51C methylated versus mutated ovarian carcinoma.
Gynecol Oncol
; 148(2): 281-285, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29233532
7.
Evaluation of Intraoperative Assessments in the Management of Endometrial Carcinoma: A Retrospective Quality Assurance Review.
Int J Gynecol Pathol
; 37(5): 414-420, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30102260
8.
Neoplastic cellularity is associated with clinical and molecular features of high-grade serous ovarian carcinoma.
Gynecol Oncol
; 143(2): 389-392, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27575909
9.
Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinoma.
Int J Gynecol Pathol
; 34(1): 57-64, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25473754
10.
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Proc Natl Acad Sci U S A
; 108(44): 18032-7, 2011 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22006311
11.
53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes.
Gynecol Oncol
; 128(3): 493-9, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23246380
12.
Characteristics of women with ovarian carcinoma who have BRCA1 and BRCA2 mutations not identified by clinical testing.
Gynecol Oncol
; 128(3): 483-7, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23262210
13.
Loss of function germline mutations in RAD51D in women with ovarian carcinoma.
Gynecol Oncol
; 127(3): 552-5, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22986143
14.
Biomarkers of progestin therapy resistance and endometrial hyperplasia progression.
Am J Obstet Gynecol
; 207(1): 36.e1-8, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22727345
15.
PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia.
Int J Gynecol Pathol
; 31(2): 151-159, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22317873
16.
Using IHC to Predict Local Recurrence/Progression of DCIS: A Search for a More Cost-effective Solution.
Breast J
; 22(2): 247-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26696338
17.
MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival.
Genes Chromosomes Cancer
; 49(7): 577-84, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20461750
18.
Imiquimod treatment of vulvar melanoma in situ invading the urethra.
Gynecol Oncol Rep
; 38: 100875, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34926757
19.
Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas.
Mol Cancer
; 8: 48, 2009 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-19602291
20.
Patterns and duration of primary and recurrent treatment in ovarian cancer patients with germline BRCA mutations.
Gynecol Oncol Rep
; 29: 113-117, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31467964